ProPhase Labs, Inc.
PRPH
$0.10
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 784.00K | 883.00K | 1.25M | 1.43M | 1.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 784.00K | 883.00K | 1.25M | 1.43M | 1.49M |
| Cost of Revenue | 537.00K | 1.01M | 513.00K | 905.00K | 1.64M |
| Gross Profit | 247.00K | -123.00K | 734.00K | 526.00K | -150.00K |
| SG&A Expenses | 5.97M | 4.64M | 4.62M | 4.09M | 17.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.51M | 5.65M | 5.14M | 5.09M | 18.78M |
| Operating Income | -5.73M | -4.76M | -3.89M | -3.66M | -17.29M |
| Income Before Tax | -8.02M | -7.00M | -3.69M | -4.68M | -19.02M |
| Income Tax Expenses | -622.00K | -157.00K | 779.00K | -- | 14.56M |
| Earnings from Continuing Operations | -7.40M | -6.84M | -4.47M | -4.68M | -33.57M |
| Earnings from Discontinued Operations | 0.00 | -- | -- | 8.64M | -786.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.40M | -6.84M | -4.47M | 3.97M | -34.36M |
| EBIT | -5.73M | -4.76M | -3.89M | -3.66M | -17.29M |
| EBITDA | -4.76M | -3.73M | -2.55M | -2.18M | -15.77M |
| EPS Basic | -0.33 | -1.65 | -1.08 | 1.13 | -14.33 |
| Normalized Basic EPS | -0.26 | -1.09 | -0.39 | -0.75 | -4.87 |
| EPS Diluted | -0.33 | -1.65 | -1.10 | 1.13 | -14.36 |
| Normalized Diluted EPS | -0.26 | -1.09 | -0.39 | -0.75 | -4.87 |
| Average Basic Shares Outstanding | 22.12M | 4.15M | 4.15M | 3.52M | 2.40M |
| Average Diluted Shares Outstanding | 22.12M | 4.15M | 4.15M | 3.52M | 2.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |